Organon (OGN) closed the most recent trading day at $16.26, moving +1.82% from the previous trading session. This change outpaced the S&P 500's 1.46% loss on the day. On the other hand ...

Organon (NYSE:OGN) is scheduled to announce Q4 earnings results on Thursday, February 13th, before market open. Analysts expect a profit of $0.87 per share (-1.1% Y/Y) on revenue of $1.59B (-0.5% ...

It focuses therapeutics in women’s health, biosimilars, and established brands. OGN is truly a diversified global company, with a presence in 140 markets and three-quarters of revenues coming ...

Organon (OGN) closed at $14.62 in the latest trading session, marking a -1.81% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.95%. Meanwhile, the Dow ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organon (OGN) reported $1.59 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 0.4%. EPS of $0.90 for the same period compares to $0.88 a year ago.

In a report released today, Jason Gerberry from Bank of America Securities reiterated a Sell rating on Organon (OGN – Research Report). The company’s shares closed yesterday at $16.32.

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Organon beat analysts’ revenue expectations by 1.1% last ...